BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15291040)

  • 21. Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration.
    Rosengart TK; Romeiser JL; White LJ; Fratello A; Fallon E; Senzel L; Shroyer AL
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1259-1266, 1266.e1; discussion 1266. PubMed ID: 23953984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [To what extent does Trasylol decrease the need for blood and blood derivatives in postoperative acetylsalicylic acid (ASA)-induced hemorrhage in CABG surgery?].
    Straus S; Vila H; Kulić M; Donlić E
    Med Arh; 2003; 57(4 Suppl 1):49-51. PubMed ID: 15017865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perioperative outcomes of cardiac surgery patients with ongoing ticagrelor therapy: boon and bane of a new drug.
    Schotola H; Bräuer A; Meyer K; Hinz J; Schöndube FA; Bauer M; Mohite PN; Danner BC; Sossalla S; Popov AF
    Eur J Cardiothorac Surg; 2014 Aug; 46(2):198-205. PubMed ID: 24420365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stopping antiplatelet medication before coronary artery bypass graft surgery: is there an optimal timing to minimize bleeding?
    Gielen CL; Bruggemans EF; Stijnen T; Eikenboom J; Tavilla G; Brand A; Klautz RJ
    Eur J Cardiothorac Surg; 2015 Oct; 48(4):e64-70. PubMed ID: 26248820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does clopidogrel increase blood loss following coronary artery bypass surgery?
    Chu MW; Wilson SR; Novick RJ; Stitt LW; Quantz MA
    Ann Thorac Surg; 2004 Nov; 78(5):1536-41. PubMed ID: 15511426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do we have to stop anticoagulant and platelet-inhibitor treatments during proctological surgery?
    Pigot F; Juguet F; Bouchard D; Castinel A
    Colorectal Dis; 2012 Dec; 14(12):1516-20. PubMed ID: 22564791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acetylsalicylic acid in patients with planned (elective) interventions on the coronary arteries. Risks and benefits].
    Altarev SS; Barbarash OL
    Kardiologiia; 2012; 52(4):60-7. PubMed ID: 22839518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thromboresistant surfaces with low-dose anticoagulation alleviate clopidogrel-related complications in patients undergoing coronary artery bypass grafting.
    Hussaini BE; Thatte HS; Rhodes BA; Treanor PR; Birjiniuk V
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):782-8. PubMed ID: 21146837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery.
    Firstenberg MS; Dyke CM; Angiolillo DJ; Ramaiahm C; Price M; Brtko M; Welsby I; Chandna H; Holmes DR; Voeltz M; Tummala P; Hutyra M; Manoukian SV; Prats J; Todd M; Liu T; Chronos N; Dietrich M; Montalescot G; Cannon LA; Topo EJ
    Heart Surg Forum; 2013 Apr; 16(2):E60-9. PubMed ID: 23625478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hybrid coronary revascularization: an overview of options for anticoagulation and platelet inhibition.
    Zimrin D; Bonatti J; Vesely MR; Lehr EJ
    Heart Surg Forum; 2010 Dec; 13(6):E405-8. PubMed ID: 21169155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenosine diphosphate-induced single-platelet count aggregation and bleeding in clopidogrel-treated patients undergoing coronary artery bypass grafting.
    Dalén M; van der Linden J; Holm M; Lindvall G; Ivert T
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):230-4. PubMed ID: 24447500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-molecular-weight heparin and other antithrombotic agents in the setting of a primarily medical treatment of unstable coronary artery disease.
    Verheugt FW
    Haemostasis; 2000; 30 Suppl 2():122-7; discussion 106-7. PubMed ID: 11251355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
    Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of aspirin on postoperative bleeding in coronary artery bypass grafting.
    Kamran M; Ahmed A; Dar MI; Khan AB
    Ann Thorac Cardiovasc Surg; 2008 Aug; 14(4):224-9. PubMed ID: 18818571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Who might benefit from early aspirin after coronary artery surgery?
    Gukop P; Gutman N; Bilkhu R; Karapanagiotidis GT
    Interact Cardiovasc Thorac Surg; 2014 Sep; 19(3):505-11. PubMed ID: 24871533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perioperative Bleeding in Patients With Acute Coronary Syndrome Treated With Fondaparinux Versus Low-Molecular-Weight Heparin Before Coronary Artery Bypass Grafting.
    Khodabandeh S; Biancari F; Kinnunen EM; Mariscalco G; Airaksinen J; Gherli R; Gatti G; Demal T; Onorati F; Faggian G; De Feo M; Santarpino G; Rubino AS; Maselli D; Salsano A; Nicolini F; Zanobini M; Ruggieri VG; Bounader K; Perrotti A; Dalén M
    Am J Cardiol; 2019 Feb; 123(4):565-570. PubMed ID: 30527774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Sustained Use of Aspirin until the Time of Surgery on Outcomes following Coronary Artery Bypass Grafting: A Randomized Clinical Trial.
    Sharifi M; Kamali A; Ghandi Y
    Thorac Cardiovasc Surg; 2018 Sep; 66(6):442-451. PubMed ID: 29172212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy?
    Mahla E; Prueller F; Farzi S; Pregartner G; Raggam RB; Beran E; Toller W; Berghold A; Tantry US; Gurbel PA
    Ann Thorac Surg; 2016 Dec; 102(6):2010-2017. PubMed ID: 27378554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative bleeding in coronary artery bypass patients on double antiplatelet therapy: predictive value of preoperative aggregometry.
    Della Corte A; Bancone C; Spadafora A; Borrelli M; Galdieri N; Quintiliano SN; Bifulco O; De Feo M
    Eur J Cardiothorac Surg; 2017 Nov; 52(5):901-908. PubMed ID: 28977378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay.
    Karthik S; Grayson AD; McCarron EE; Pullan DM; Desmond MJ
    Ann Thorac Surg; 2004 Aug; 78(2):527-34; discussion 534. PubMed ID: 15276512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.